IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
May 08, 2019 07:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, May 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has entered into a...
IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA
April 02, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, April 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced it has received a Complete...
IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results
March 22, 2019 16:05 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, March 22, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter...
IntelGenx Granted Japanese Patent for RIZAPORT® VersaFilm™
February 11, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Feb. 11, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has received a Decision...
IntelGenx Strengthens Senior Management Team
February 07, 2019 16:00 ET
|
IntelGenx Technologies Corp.
SAINT-LAURENT, Québec, Feb. 07, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT), today announced that it has strengthened its management team with the...
IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA
January 30, 2019 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the U.S. Food and Drug...
IntelGenx Partners with Gensco® Pharma to Market RIZAPORT® in the United States
December 12, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Dec. 12, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive...
IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT®
November 20, 2018 08:00 ET
|
IntelGenx Technologies Corp.
- PDUFA Goal Date of April 1, 2019 - SAINT LAURENT, Quebec, Nov. 20, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that its...